{"id":"https://openalex.org/W2397526443","doi":null,"title":"Erratum to \"IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer\" [Clin. Lab. 2012; 58:501-505].","display_name":"Erratum to \"IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer\" [Clin. Lab. 2012; 58:501-505].","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2397526443","mag":"2397526443","pmid":"https://pubmed.ncbi.nlm.nih.gov/23163132"},"language":"en","primary_location":{"id":"pmid:23163132","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23163132","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical laboratory","raw_type":"Journal Article"},"volume":null,"type":"erratum","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000442883","display_name":"Ay\u015feg\u00fcl Karg\u0131","orcid":"https://orcid.org/0000-0003-4797-7313","observed_orcids":["https://orcid.org/0000-0003-4797-7313"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aysegul Kargi","raw_affiliation_strings":["Oncology Unit, Denizli Education and Research Hospital, Denizli, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Unit, Denizli Education and Research Hospital, Denizli, Turkey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014233084","display_name":"Arzu Didem Yal\u00e7\u0131n","orcid":"https://orcid.org/0000-0002-0615-5279","observed_orcids":["https://orcid.org/0000-0002-0615-5279"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arzu Didem Yalcin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048580605","display_name":"Nuray Erin","orcid":"https://orcid.org/0000-0002-6116-1970","observed_orcids":["https://orcid.org/0000-0002-6116-1970"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nuray Erin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051103188","display_name":"Burhan Sava\u015f","orcid":"https://orcid.org/0009-0000-0815-3237","observed_orcids":["https://orcid.org/0009-0000-0815-3237"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Burhan Savas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"H H\u00fcseyin Polat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H H\u00fcseyin Polat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5013168738","display_name":"Reginald M. Gorczynski","orcid":"https://orcid.org/0000-0002-5622-2855","observed_orcids":["https://orcid.org/0000-0002-5622-2855","https://orcid.org/0000-0002-3206-2519"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reginald M Gorczynski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"58","issue":"9-10","first_page":"1103","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.020899999886751175,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/soluble-trail","display_name":"soluble TRAIL","score":0.8389999866485596},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.984000027179718},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9829999804496765},{"id":"https://openalex.org/keywords/anti-vegf-monoclonal-antibody","display_name":"anti-VEGF monoclonal antibody","score":0.9380000233650208},{"id":"https://openalex.org/keywords/metastatic-colon-cancer","display_name":"metastatic colon cancer","score":0.9710000157356262},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8370000123977661},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7459999918937683},{"id":"https://openalex.org/keywords/serum-cytokine-levels","display_name":"serum cytokine levels","score":0.7020000219345093},{"id":"https://openalex.org/keywords/treatment-efficacy-marker","display_name":"treatment efficacy marker","score":0.6079999804496765},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor-inhibition","display_name":"vascular endothelial growth factor inhibition","score":0.8019999861717224}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.9453639984130859},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9202843904495239},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7904847860336304},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6790178418159485},{"id":"https://openalex.org/C68324877","wikidata":"https://www.wikidata.org/wiki/Q421859","display_name":"Interleukin 8","level":3,"score":0.5829360485076904},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5743250846862793},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5291730761528015},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5091111063957214},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.47565409541130066},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.42590463161468506},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4111676812171936},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3977389931678772},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.31102555990219116},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30944621562957764},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.26846620440483093},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.2158258855342865}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016209","descriptor_name":"Interleukin-8","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D053221","descriptor_name":"TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:23163132","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23163132","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical laboratory","raw_type":"Journal Article"},{"id":"mag:2397526443","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23163132","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2460779682","https://openalex.org/W2154922612","https://openalex.org/W2965465762","https://openalex.org/W181692252","https://openalex.org/W2900902431","https://openalex.org/W108238438","https://openalex.org/W1966804416","https://openalex.org/W4378977999","https://openalex.org/W2808977261","https://openalex.org/W2889666951"],"abstract_inverted_index":{"BACKGROUND:":[0],"Colorectal":[1],"cancer":[2,9,16,88,143,321],"is":[3,20],"the":[4,11,33,43,100,113,135,219,252],"third":[5,12],"most":[6],"common":[7],"human":[8],"and":[10,49,56,75,97,120,127,145,155,181,241,245,291],"leading":[13],"cause":[14],"of":[15,35,45,53,116,137,171,197,209,307],"related":[17],"death.":[18],"BevacizumAb":[19,139,188,230,253,277,281,312],"a":[21,236],"humanized":[22],"monoclonal":[23],"antibody":[24],"developed":[25],"against":[26],"vascular":[27],"endothelial":[28],"growth":[29],"factor":[30],"(VEGF)":[31],"for":[32,235],"treatment":[34,54,254,313],"metastatic":[36,61,86,141,319],"cancers.":[37],"Our":[38,303],"goal":[39],"was":[40,67,92],"to":[41,169,264],"evaluate":[42],"possibility":[44],"using":[46],"serum":[47,160,283],"sTRAIL":[48,126,161,190,227,239,249,310],"IL8":[50,128,268,284],"as":[51],"markers":[52],"efficacy":[55],"prognosis":[57],"in":[58,69,99,112,134,163,195,226,272,288,294,309,318],"patients":[59,80,103,109,144,164,201,217,274],"with":[60,85,106,205,258,300],"colon":[62,87,142,320],"cancer.":[63],"METHODS:":[64],"The":[65,159],"study":[66],"conducted":[68],"Denizli":[70,117],"between":[71,238],"November":[72],"10,":[73],"2009":[74],"September":[76],"20,":[77],"2010.":[78],"25":[79,138,198],"(6":[81],"female,":[82],"19":[83],"male)":[84],"whose":[89],"mean":[90],"age":[91],"58.7":[93],"years,":[94],"were":[95,110,121,130,152,167,192,218,255,270,286,297],"selected":[96],"included":[98],"study.":[101],"All":[102,108],"received":[104,276],"therapy":[105,166],"BevacizumAb.":[107],"followed":[111],"Oncology":[114],"Clinic":[115],"State":[118],"Hospital":[119],"evaluated":[122],"by":[123,132],"clinical":[124],"status.":[125],"levels":[129,228,240,250,269,285,296],"measured":[131],"ELISA":[133],"sera":[136],"treated":[140],"20":[146],"healthy":[147,172],"age-gender":[148,173],"matched":[149,174],"controls.":[150],"Measurements":[151],"taken":[153],"before":[154,165],"after":[156,229,251],"treatment.":[157,231],"RESULTS:":[158],"concentrations":[162],"similar":[168],"those":[170],"controls,":[175],"namely":[176],"1.23":[177],"+/-":[178,183,212],"0.06":[179],"ng/mL":[180],"1.21":[182],"0.04":[184],"ng/mL,":[185],"respectively.":[186],"After":[187],"treatment,":[189],"ratios":[191],"increased":[193,259],"significantly":[194,256],"11":[196],"patients.":[199,322],"14":[200,216],"showed":[202,223],"progressive":[203],"disease":[204,301],"median":[206,260],"overall":[207,242,261],"survival":[208,243,262],"only":[210],"8.1":[211],"0.4":[213],"months.":[214,266],"These":[215],"same":[220],"ones":[221],"who":[222,275],"no":[224],"increase":[225],"We":[232],"explored":[233],"evidence":[234],"correlation":[237],"rates":[244],"observed":[246],"that":[247],"elevated":[248],"associated":[257],"up":[263],"22.6":[265],"Serum":[267],"decreased":[271,287],"all":[273,289],"therapy.":[278],"CONCLUSIONS:":[279],"In":[280],"therapy,":[282],"patients,":[290],"thus,":[292],"changes":[293,308],"such":[295],"not":[298],"correlated":[299],"outcome.":[302],"data":[304],"suggest":[305],"measurement":[306],"following":[311],"may":[314],"have":[315],"prognostic":[316],"value":[317]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}